All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

382

Reset

382 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • DISC-0974Phase 22 trials

    Disc Medicine, Inc · Anemia, Inflammatory Bowel Disease (IBD), Inflammatory Bowel Disease (IBD); Anemia

  • EB-DNK101 dual-targeting CAR-NK cellsMSLN + MUC1Phase 22 trials

    Beijing Biotech · Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced or Metastatic Disease, Unresectable Locally Advanced

  • EB-DNK102 dual-targeting CAR-NK cellsCLDN18.2 + MUC1Phase 22 trials

    Beijing Biotech · Pancreatic Ductal Adenocarcinoma (PDAC), Unresectable Locally Advanced or Metastatic Disease, Unresectable Locally Advanced

  • ECC4703Phase 22 trials

    Eccogene · Adult Obesity, Weight Management, Metabolic Dysfunction-associated Steatohepatitis

  • EfinopegdutideMK-6024, HM12525APhase 22 trials

    Merck & Co. · Non-alcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic

  • ERAS-007Phase 22 trials

    Erasca, Inc. · Advanced or Metastatic Solid Tumors, Metastatic Colorectal Cancer, Metastatic Pancreatic Ductal Adenocarcinoma

  • GKL-006iNKT cellsPhase 22 trials

    Beijing Gene Key Life Technology Co., Ltd · Advanced Pancreatic Cancer, Ductal Adenocarcinoma of Pancreas, Hepatocellular Carcinoma (HCC)

  • HU6Phase 22 trials

    Rivus Pharmaceuticals, Inc. · Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Fatty Liver

  • ICG318Phase 22 trials

    iCell Gene Therapeutics · Inflammatory Bowel Diseases (IBD), Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)

  • ImzokitugBMS-986340Phase 22 trials

    Bristol Myers Squibb · Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC), Cervical Cancer

  • KN046Recombinant Humanized PD-L1, CTLA-4 Bispecific Single Domain Antibody Fc Fusion ProteinPhase 22 trials

    InxMed (Shanghai) Co., Ltd. · Pancreatic Cancer, Advanced Non-small Cell Lung Cancer

  • LY188011Phase 22 trials

    Eli Lilly · Neoplasms, Child, Adolescent

  • NLM-001Phase 22 trials

    Nelum Corp · Untreated, Advanced Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma

  • NNC0194-0499Phase 22 trials

    Novo Nordisk · Alcohol-related Liver Disease, Non-alcoholic Steatohepatitis

  • ODM-212Phase 22 trials

    Orion Corporation, Orion Pharma · Solid Tumours, Mesothelioma, Pancreatic Cancer

  • Olaptesed pegolNOX-A12Phase 22 trials

    TME Pharma AG · Metastatic Pancreatic Cancer, Glioblastoma

  • QHL-1618ALK-N001Phase 22 trials

    Zhejiang Anglikang Pharmaceutical Co., Ltd. · Advanced Gastrointestinal Tumors, Advanced Solid Tumors

  • S095029Phase 22 trials

    Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC), MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer

  • SAR445877Phase 22 trials

    Sanofi · Solid Tumor, Gastric Cancer, Oesophageal Carcinoma

  • SelicrelumabPhase 22 trials

    Roche (Genentech) · Metastatic Breast Cancer, Pancreatic Adenocarcinoma

  • SGC001Phase 22 trials

    Beijing Sungen Biomedical Technology Co., Ltd · Acute Anterior ST-Segment Elevation Myocardial Infarction, Acute Pancreatitis

  • SKB500Phase 22 trials

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Esophageal Squamous Cell Carcinoma, Small Cell Lung Cancer

  • SolrikitugPhase 22 trials

    Uniquity One (UNI) · Eosinophilic Esophagitis (EoE), COPD

  • SPY001SPY001-001Phase 22 trials

    Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis

  • SPY002SPY002-091Phase 22 trials

    Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis

  • SPY003SPY003-207Phase 22 trials

    Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis

  • TQB2916Phase 22 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Soft Tissue Sarcoma, Melanoma, Pancreatic Cancer

  • TQB6411Phase 22 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Advanced Lung Cancer, Esophageal Cancer

  • TRK-950Phase 22 trials

    Toray Industries, Inc · Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

  • TST001Phase 22 trials

    Transcenta Therapeutics (Hangzhou) Co., Ltd. · Advanced Cancer, Gastric Cancer, Gastroesophageal-junction Cancer

  • TU2218Phase 22 trials

    TiumBio Co., Ltd. · Advanced Solid Tumor, Solid Tumor, Biliary Tract Cancer

  • VG2025Phase 22 trials

    Virogin Biotech Ltd. · Intrahepatic Cholangiocarcinoma, Colorectal Cancer With Hepatic Metastases

  • VolixibatSHP626Phase 22 trials

    Mirum Pharmaceuticals, Inc. · Primary Sclerosing Cholangitis, Primary Biliary Cholangitis, PBC

  • XNW27011ASP546CPhase 22 trials

    Astellas · Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic

  • ZalifrelimabPhase 22 trials

    ImmunoGenesis · Metastatic Prostate Cancer, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Cancer

  • AFNT-211Phase 21 trial

    Affini-T Therapeutics, Inc. · Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer, Colorectal Cancer

  • Aldoxorubicin HClPhase 21 trial

    ImmunityBio, Inc. · Pancreatic Cancer

  • AMP945Phase 21 trial

    Amplia Therapeutics Limited · Pancreatic Cancer, PDAC, Pancreatic Ductal Adenocarcinoma

  • AMXI-5001Phase 21 trial

    AtlasMedx, Incorporated · Advanced Malignant Neoplasm, Breast Cancer, Ovarian Cancer

  • ANG003Phase 21 trial

    Anagram Therapeutics, Inc. · Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)

  • ANO31905Phase 21 trial

    Anova Innovation Limited · Pancreatic Cancer

  • AP203Phase 21 trial

    AP Biosciences Inc. · Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC)

  • APL-101Phase 21 trial

    Apollomics Inc. · Solid Tumors, Advanced Cancer, Renal Cancer

  • ART0380Phase 21 trial

    Artios Pharma Ltd · Advanced Cancer, Metastatic Cancer, Ovarian Cancer

  • ATH-063Phase 21 trial

    Athos Therapeutics Inc · Ulcerative Colitis, Inflammatory Bowel Diseases, Autoimmune Diseases

  • AVZO-1418Phase 21 trial

    Avenzo Therapeutics, Inc. · Solid Tumor Cancer, Locally Advanced, Metastatic Solid Tumors

  • AZD2693Phase 21 trial

    AstraZeneca · Nonalcoholic Steatohepatitis

  • AZD4360Phase 21 trial

    AstraZeneca · Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer

  • AZD5863Phase 21 trial

    AstraZeneca · Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma

  • AZD6750Phase 21 trial

    AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)

NewerPage 5 of 8Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.